These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34931125)

  • 1. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
    Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis.
    Wang M; Shan Y; Sun W; Han J; Tong H; Fan M; Chen J; Yu P; Shen L; Chen X
    Front Pharmacol; 2021; 12():751050. PubMed ID: 34795585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Network Meta-analysis of Chinese patent medicines in treatment of coronary heart disease complicated with heart failure].
    Wang AL; Wei JJ; Sun Y; Guo HX; Zhang MJ; Lu JF; Zhang YL; Peng GC; Zhu MJ
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):518-533. PubMed ID: 38403327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials.
    Wei J; Ma T; Zhou C; Hao P; Li B; Wang X; Yu R; Zhu M; Wang Y
    Front Pharmacol; 2022; 13():1002713. PubMed ID: 36452225
    [No Abstract]   [Full Text] [Related]  

  • 5. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].
    Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meta-analysis of efficacy and safety of Shexiang Tongxin Dripping Pills combined with conventional therapy of coronary heart disease].
    Pan J; Zhou JM; Wang XM; Zuo KN; Wang ZH; Lu SQ; Wang W; Zhu WT
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2325-2332. PubMed ID: 34047137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis.
    Dong T; Wang J; Ma X; Ma R; Wen J; Chen N; Xie Q
    Evid Based Complement Alternat Med; 2018; 2018():6949348. PubMed ID: 29849724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
    Wen J; Ma X; Zhang L; Lu X; Yang Y; Wang J; Zhao Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13580. PubMed ID: 30572460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis.
    Li Y; Li D; Wang W; Li X; Li P; Zhang Y; Lin Q; Li Y
    Front Cardiovasc Med; 2022; 9():1029387. PubMed ID: 36479564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive effect of Naoxintong capsule combined with Western medicine on coronary heart disease after percutaneous coronary intervention: a meta-analysis.
    Yu L; Huang P; Wang M; Li Z; Cai H; Feng Y; Wu L; Peng W; Zeng J; Chen B
    Front Pharmacol; 2024; 15():1274000. PubMed ID: 38590642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
    Yang Y; Gao S; Fang Q; Zhu M
    Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review.
    Zhou Z; Shen W; Yu L; Xu C; Wu Q
    J Ethnopharmacol; 2016 Dec; 194():1130-1139. PubMed ID: 27847338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Traditional Chinese Medicine Cutaneous Regions Therapy as adjuvant treatment of chronic heart failure: A systematic review and meta-analysis.
    Li M; Li H; Liu H; Lai X; Xing W; Shang J
    Heliyon; 2023 May; 9(5):e16012. PubMed ID: 37206004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
    Mei J; Xu H; Xu FQ; Ju JQ
    Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Chinese Herbal Medicine for Depressive Disorder in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Xue YJ; Xie Y; Zhao GL; Zhou BD; Li K; Li SY; Zhang P
    Chin J Integr Med; 2020 Aug; 26(8):617-623. PubMed ID: 31222629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety evaluation of Shenmai injections for dilated cardiomyopathy: A systematic review and meta-analysis of randomised controlled trials.
    Wang Y; Liu Q; Kong Y; Zhong G; Wang D
    Phytomedicine; 2023 Feb; 110():154630. PubMed ID: 36608499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis.
    Chen M; Liu M; Guo X; Zhou J; Yang H; Zhong G; Men L; Xie Y; Tong G; Liu Q; Luan J; Zhou H
    Phytomedicine; 2022 Sep; 104():154243. PubMed ID: 35717809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention.
    Liu HY; Wang W; Shi DZ; Ge JB; Zhang L; Peng J; Wang CL; Wang PL
    Chin J Integr Med; 2012 Jun; 18(6):423-30. PubMed ID: 22382523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
    Shi L; Huang L; Yin E; Deng J; Du X
    PLoS One; 2023; 18(12):e0295344. PubMed ID: 38048301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease.
    Li C; Li Q; Xu J; Wu W; Wu Y; Xie J; Yang X
    Evid Based Complement Alternat Med; 2020; 2020():5067137. PubMed ID: 33281912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.